No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Distribution
Henry Schein, Inc. operates as a global purveyor of healthcare goods and services, catering to a diverse international customer base. Its clientele spans dental professionals and laboratories, physician practices, governmental entities, established healthcare institutions, and various alternative care providers. The company's activities are organized into two primary divisions: Healthcare Distribution, and Technology and Value-Added Services. Within its Healthcare Distribution arm, Henry Schein delivers an extensive array of dental and medical provisions. Its dental inventory includes vital products for infection control, instruments such as handpieces, preventative materials, impression compounds, restorative composites, anesthetics, prosthetic teeth, dental implants, gypsum, acrylics, articulators, and abrasives. Major equipment offerings comprise dental chairs, delivery systems, lighting units, X-ray supplies and machinery, personal protective equipment, and advanced digital restoration devices, along with maintenance services for this equipment. For medical clients, this segment furnishes both proprietary and generic pharmaceuticals, immunizations, surgical instruments, diagnostic kits, sterile supplies, radiography products, general medical equipment, and nutritional supplements. The Technology and Value-Added Services division focuses on providing specialized software, innovative technological platforms, and supplementary services. A key offering in this segment includes comprehensive practice management software systems designed for both dental and medical professionals. Additionally, it offers a suite of practice-enhancing solutions such as non-recourse financial assistance, electronic services, dedicated practice technology and network support, hardware services, ongoing professional development courses for practitioners, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
www.henryschein.comNo one on the platform currently holds 0L3C.L.
No tracked institution reports a position in 0L3C.L as of their last filing.
No one on the platform has traded 0L3C.L yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 8.5% | 11.1% | 11.8% | — | — | — |
| Rev. Growth % | 4.0% | 5.4% | ||||
| Profit Margin % | 3.0% | 3.8% | 4.1% | |||
| Free Cash Flow Margin % | 4.3% | 4.4% | 4.8% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $13.9B | +6.0% | $5.38 | $5.32–$5.48 | — | 1 |
| 2027 | $14.4B | +4.0% | $6.01 | $5.94–$6.11 | — | 1 |
| 2028 | $15.0B | +4.0% | $6.63 | $6.55–$6.74 | — | 1 |
| 2029 | $15.8B | +5.2% | $6.97 | $6.89–$7.09 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-04 | $1.24 | $1.27 | +2.4% |
| 2026-05-05 | $1.22 | $1.32 | +8.2% |
| 2026-02-24 | $1.30 | $1.34 | +3.1% |
| 2025-11-04 | $1.28 | $1.38 | +7.8% |
| 2025-08-05 | $1.19 | $1.10 | -7.6% |
| 2025-05-05 | $1.11 | $1.15 | +3.6% |
| 2025-02-25 | $1.20 | $1.19 | -0.8% |
| 2024-11-05 | $1.17 |
| $1.22 |
| +4.3% |
| +0.64% |
| $13.1B |
| — |
| 0I8F.LDENTSPLY SIRONA Inc. | $10.00 | -0.31% | $2.0B | — |
| 0J2O.LHalozyme Therapeutics, Inc. | $106.43 | -0.08% | $12.6B | — |
Source: Financial Modeling Prep · peers by sector/industry